34 reports of this reaction
3.6% of all CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE reports
#3 most reported adverse reaction
RENAL FAILURE is the #3 most commonly reported adverse reaction for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, manufactured by Actavis Pharma, Inc.. There are 34 FDA adverse event reports linking CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE to RENAL FAILURE. This represents approximately 3.6% of all 933 adverse event reports for this drug.
Patients taking CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL FAILURE is moderately reported among CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE users, representing a notable but not dominant share of adverse events.
In addition to renal failure, the following adverse reactions have been reported for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE:
The following drugs have also been linked to renal failure in FDA adverse event reports:
RENAL FAILURE has been reported as an adverse event in 34 FDA reports for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL FAILURE accounts for approximately 3.6% of all adverse event reports for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, making it one of the most commonly reported side effect.
If you experience renal failure while taking CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.